(Q44878674)

7 December 2017

Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients (English)

1 reference

7 December 2017

1 reference

Maryann B Flick

1

1 reference

7 December 2017

David O'Malley

2

1 reference

7 December 2017

Thomas Rutherford

3

1 reference

7 December 2017

Sofya Rodov

4

1 reference

7 December 2017

Marijka Kamsteeg

5

1 reference

7 December 2017

Xiao-Ying Hao

6

1 reference

7 December 2017

Peter Schwartz

7

1 reference

7 December 2017

Barry M Kacinski

8

1 reference

7 December 2017

Gil Mor

9

1 reference

7 December 2017

1 May 2004

1 reference

7 December 2017

Reproductive Sciences

1 reference

7 December 2017

11

1 reference

7 December 2017

252-259

1 reference

7 December 2017

4

1 reference

7 December 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

The clinical relevance of chemosensitivity testing in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Apoptosis in cancer therapy: crossing the threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Apoptosis induced by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Caspases: the executioners of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

The Apaf-1 apoptosome: a large caspase-activating complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Second-line treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Roles of Fas and Fas ligand during mammary gland remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2003.11.003

10.1016/J.JSGI.2003.11.003

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference